Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 23 - Anaesthetics
Patents for A61P 23 - Anaesthetics (4,141)
11/2003
11/27/2003WO2003007802A3 Pharmaceutical combinations of oxycodone and naloxone
11/27/2003WO2002067903A3 Compositions and methods of manufacture for oral dissolvable dosage forms
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/26/2003EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
11/26/2003EP1363602A1 Local anesthetic, and method of use
11/20/2003WO2003000699A8 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/13/2003WO2003092652A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003WO2003092651A1 Warming and nonirritating lubricant compositions
11/13/2003WO2003041648A3 High-concentration lidocaine compositions and methods for their preparation
11/13/2003US20030212143 Analgesics, anesthetics; crystallization, resolution
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211140 Lipid encapsulating hydrophobic core; drugs; anesthetic
11/13/2003CA2484329A1 Warming and nonirritating anhydrous lubricant compositions
11/12/2003EP1032390B1 Anaesthetic formulation
11/12/2003EP0979087B1 Analgesic combination
11/12/2003EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
11/06/2003WO2003034900A3 Sterile, breathable patch for treating wound pain
11/06/2003WO2003032985A3 Concomitant oral and topical administration of anti - infective agents
11/06/2003US20030207772 Warming and nonirritating lubricant compositions and method of comparing irritation
11/05/2003EP1357906A2 Blockade of sodium channels by phenol derivatives
11/05/2003CN1454085A Clear aqueous anaesthetic composition
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/2003
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1105096B1 Injectable aqueous dispersions of propofol
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638966 Use of melatonin analogues for induction of general anesthesia
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/23/2003WO2003086413A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199477 Use of gellable pharmaceutical compositions in periodontology
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003CN1124845C Proopofol microdroplet formulations
10/16/2003WO2003007802A9 Pharmaceutical combinations of oxycodone and naloxone
10/15/2003EP1351669A1 Clear propofol compositions
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/09/2003US20030191070 Medical composition kit for treating lesioned abnormal tissue
10/08/2003EP1350522A1 Topical anesthesia compositions
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003070177A3 Use of melatonin analogues for induction of general anesthesia
10/02/2003WO2003063898A3 Method of treating pain with botulinum toxin
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/01/2003EP1348466A2 Method for treating pain with adenosine-tetraphosphates
09/2003
09/30/2003US6627620 Composition set and kit for use in intraocular surgery
09/25/2003WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
09/25/2003US20030180395 Anxiolytic agents; analgesics; sleep disorders; antiinflammatory agents; central nervous system disorders
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/18/2003WO2003076414A2 Aryl substituted pyrimidines and the use thereof
09/18/2003WO2003075850A2 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003US20030175357 Prolonged anesthesia in joints and body spaces
09/18/2003CA2479036A1 Aryl substituted pyrimidines and the use thereof
09/18/2003CA2477973A1 Methods for alzheimer's disease treatment and cognitive enhancement
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/16/2003US6620435 Compositions for topical application of therapeutic agents
09/16/2003US6620423 Ropivacaine for use as an analgesic in the treatment of muskuloskeletal pain
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/11/2003US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/09/2003CA2304096C Sustained-release liposomal anesthetic compositions
09/04/2003WO2003072544A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003US20030165544 Injectable aqueous dispersions of propofol
09/04/2003CA2477634A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/03/2003EP0833612B1 New pharmaceutical composition with anaesthetic effect
09/03/2003CN1119997C Percutaneous tap preparation containing fentanyl
09/02/2003US6613803 Treating, preventing or ameliorating pain
08/2003
08/28/2003WO2003070177A2 Use of melatonin analogues for induction of general anesthesia
08/28/2003WO2002040005A3 Blockade of sodium channels by phenol derivatives
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/21/2003WO2003068200A2 Novel therapeutic application for a composition
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003030862A3 Anaesthetic compositions and method for their administration
08/21/2003WO2003026632A3 Substituted phenol compounds useful for anesthesia and sedation
08/21/2003US20030158147 Method for treating pain
08/20/2003EP1336409A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003015699A3 Topical compositions and methods for treating pain
08/14/2003US20030153554 Short-acting sedative hypnotic agents for anesthesia and sedation
08/14/2003US20030152637 Administering by injection; glycolic acid-lactic acid copolymer; sustained release particles
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/07/2003WO2003063898A2 Method of treating pain with botulinum toxin
08/07/2003WO2003063824A2 Pharmaceutical composition
08/07/2003WO2003063779A2 Selective analgesic agents
08/07/2003CA2474710A1 Freeze-dried pharmaceutically acceptable inclusion complexes of propofol and cyclodextrin
08/07/2003CA2474306A1 Selective analgesic agents
08/06/2003EP1244498B1 Combination of trimebutine with an opioid analgesic
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
07/2003
07/31/2003WO2003061634A1 Sustained release pharmaceutical composition
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 42